Latest news from across our Group

17-Nov-22

Capital Markets Event

10-Nov-22

Convatec Group Plc Trading update for the ten months ended 31 October 2022

04-Aug-22

Interim Results for the six months ended 30 June 2022

18-May-22

New survey finds 87% of patients with long-term health conditions face stigma; nurses feel they lack time and resources to provide adequate support

12-May-22

AGM trading update for the four months ended 30 April 2022

09-May-22

Convatec invests in BlueWind Medical to fund development of innovative neuromodulation technology

14-Mar-22

Convatec Group completes acquisition of Triad Life Sciences Inc as it enters attractive wound biologics segment1

08-Mar-22

Annual Results for the twelve months ended 31 December 2021

28-Feb-22

Non-Executive Directors - Appointment and Resignation

28-Jan-22

Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc

27-Jan-22

Board Committee Changes